W W Grainger Inc vs Tilray Brands Inc — how do they compare? W W Grainger Inc trades at $1,394.9 (market cap $64.75B), while Tilray Brands Inc trades at $4.34 (market cap $541.36M). The key difference: W W Grainger Inc is far larger — about 119.6× Tilray Brands Inc's market cap, and W W Grainger Inc pays a 0.68% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| GWW | TLRY | |
|---|---|---|
Market Cap | $64.75B | $541.36M |
Sector | Technology | Health |
52-Week High | $1.39K | $21.00 |
52-Week Low | $918.18 | $4.31 |
Enterprise Value | $66.84B | $638.50M |
Dividend Yield | 0.68% | — |
Signals from Pluang's Aura AI — not financial advice
GWW trades at $1,391.07, up 1.46% with strong technical momentum and bullish moving averages. The company reported solid Q1 2026 earnings of $11.65 per share, beating estimates, and raised full-year guidance. With revenue growth to $18.4B and net profit margin improving to 9.69%, fundamentals remain robust despite elevated valuation multiples.
Outlook remains positive with analyst consensus price target of $1,260 offering modest upside. Key risks include high P/E ratio of 36.88 and competitive pressures in industrial distribution. The stock presents a quality growth opportunity but requires monitoring of valuation sustainability amid economic uncertainties.
TLRY trades at $4.36, down 0.57% on the day, amid a bearish technical signal and mixed quarterly earnings. The company reported a net loss of -$2.19 billion for 2025 despite revenue growth to $821 million, with a negative net income margin of -156.67%. Recent developments include medical cannabis expansion in Panama and the acquisition of HelloMD to enhance digital healthcare capabilities.
While low valuation ratios (P/S of 0.55, P/B of 0.35) suggest potential undervaluation, persistent losses and negative cash flow from operations pose significant risks. Analyst sentiment is cautious with a 'Hold' consensus, reflecting concerns over profitability despite growth initiatives. The stock's outlook hinges on achieving sustainable profitability and navigating competitive and regulatory pressures.
Trailing returns across standard periods
Latest headlines on both assets
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →